SECUKINUMAB

UNII: DLG4EML025
Preferred Substance Name: SECUKINUMAB

1229022-83-6
AIN457
AIN-457
AIN457A
COSENTYX
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HOMO SAPIENS MONOCLONAL ANTIBODY
SECUKINUMAB (GENETICAL RECOMBINATION)
SECUKINUMAB [INN]
SECUKINUMAB [JAN]
SECUKINUMAB [MI]
SECUKINUMAB [PURPLE BOOK CDER]
SECUKINUMAB [USAN]
SECUKINUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

SECUKINUMAB

Synonyms and Mappings

Resources

Note